Tango Therapeutics (TNGX) EBT Margin (QoQ) (2020 - 2025)

Tango Therapeutics (TNGX) EBT Margin (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tango Therapeutics 3.94 Bn 3.78 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 124,981.00
Jun 30, 2025 -48,140.00
Mar 31, 2025 17,489.00
Dec 31, 2024 -66,297.00
Sep 30, 2024 -12,259.00
Jun 30, 2024 45,706.00
Mar 31, 2024 -1,972.00
Dec 31, 2023 -35,834.00
Sep 30, 2023 -6,580.00
Jun 30, 2023 34,431.00
Mar 31, 2023 -3,326.00
Dec 31, 2022 -3,269.00
Sep 30, 2022 1,089.00
Jun 30, 2022 710.00
Mar 31, 2022 -5,520.00
Dec 31, 2021 -9,487.00
Sep 30, 2021 -26,286.00
Jun 30, 2021 16,355.00
Mar 31, 2021 -18,653.00
Dec 31, 2020 23,612.00